HashKey’s upcoming Hong Kong listing will test investor confidence in fully regulated cryptocurrency exchanges. The IPO marks a major moment for Hong Kong’s push to become a leading hub for compliant digital asset platforms. HashKey has officially received approval to proceed with its Hong Kong listing process. This decision comes as the company continues to [...]]]>HashKey’s upcoming Hong Kong listing will test investor confidence in fully regulated cryptocurrency exchanges. The IPO marks a major moment for Hong Kong’s push to become a leading hub for compliant digital asset platforms. HashKey has officially received approval to proceed with its Hong Kong listing process. This decision comes as the company continues to [...]]]>

HashKey Positions for Hong Kong Listing in Push for Trusted Crypto Services

  • HashKey’s upcoming Hong Kong listing will test investor confidence in fully regulated cryptocurrency exchanges.
  • The IPO marks a major moment for Hong Kong’s push to become a leading hub for compliant digital asset platforms.

HashKey has officially received approval to proceed with its Hong Kong listing process. This decision comes as the company continues to expand its services, strengthen cross-jurisdictional compliance, and increase its appeal to institutions that have previously preferred to await regulatory clarity before making the plunge.

How HashKey Built Its Compliance Foundation Ahead of the Listing

Prior to this good news, HashKey had been laying the groundwork since the beginning of the year, when the group obtained VASP approval from regulators, an achievement we previously reported on as part of their global compliance strategy.

Furthermore, the group also received permission from the Irish Central Bank to align its operations with the European Union’s AMLD5 framework, a move signaling that their service expansion is designed to reach global institutions seeking a digital asset service provider with stringent compliance standards.

Furthermore, the company is strengthening its product offering with a series of new launches. Last April, we highlighted the launch of Asia’s first XRP Tracker Fund by HashKey Capital, with Ripple serving as the anchor investor. This product is specifically geared towards institutions seeking crypto exposure without having to deal with the technical complexities of token custody.

In addition, the firm also offers the HashKey 20 Index Fund, adding a variety of curated investment options for investors looking to more conveniently monitor the performance of the largest digital assets.

All of these initiatives are integrated with HashKey’s growing ecosystem, which includes a crypto exchange and custodian, as well as wealth management and asset tokenization services.

Heading up to its Hong Kong IPO, HashKey is said to be in a strong position. Even without full annual disclosures, multiple reports estimate that the firm moved close to $81.9 billion in trading volume in 2024, brought in about $92.6 million in revenue, and posted a loss of nearly $99.3 million. HashKey reports carrying close to $212 million in cash and equivalents, together with about $76 million in digital asset holdings.

Furthermore, HashKey closed a $100 million raise at the start of 2024, putting its valuation above $1.3 billion. The fresh capital has been funneled into shoring up infrastructure and building new products that institutions now expect as part of a mature platform.

]]>
Market Opportunity
CyberKongz Logo
CyberKongz Price(KONG)
$0.001661
$0.001661$0.001661
+0.42%
USD
CyberKongz (KONG) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23